This document discusses biomedical waste management. It begins by defining biomedical waste and listing the major sources where it is generated, such as hospitals, labs, and research centers. It then describes how waste is categorized and segregated according to color-coded bags in India's Biomedical Waste Management Rules of 2016. The various treatment and disposal methods are also outlined, including incineration, autoclaving, and sending waste to a common biomedical waste treatment facility. Proper waste segregation, treatment, and disposal are crucial to prevent infections and protect public health.
This document discusses tuberculosis (TB) epidemiology in India. It provides background on TB, including that it is caused by Mycobacterium tuberculosis bacteria and primarily affects the lungs. It then summarizes India's high TB burden, with 20% of global cases and high incidence, prevalence, and mortality rates. Key facts presented on India include that it has the world's highest TB burden, an annual risk of infection of 1.5%, and accounts for 66% of the Southeast Asia region's cases. Treatment success rates and trends in incidence, prevalence, and multi-drug resistant TB in India from 2011 are also briefly outlined.
Waste generated from medical facilities like hospitals can contaminate the environment if not properly disposed of. There are different categories of biomedical waste including infectious waste, sharp waste, and chemical/pharmaceutical waste. Improper management of biomedical waste poses health risks like infections. Proper practices like waste segregation, storage, transportation and treatment are required by law. Source reduction through minimizing waste generation and reuse is important to reduce the impact of biomedical waste. Public participation through education is needed to ensure safe disposal of all types of waste.
The document discusses the management of healthcare waste. It defines healthcare waste as any waste generated during diagnosis, treatment or immunization of humans or animals in healthcare facilities. It notes that healthcare waste requires safe handling due to its potential for infection and injury. It then outlines the types of healthcare waste and provides examples, as well as treatment and disposal options according to regulations. Finally, it discusses how healthcare waste is managed and treated in Pimpri Chinchwad, with waste being collected and transported daily to an incinerator facility.
Health technology assessment- Dr. Saraswathy MD, PGIMERYogesh Arora
This document provides an overview of health technology assessment (HTA), including its need, scope, and current status. It discusses:
1. The growing need for priority setting and efficient resource allocation in health systems has led to the rise of HTA globally and in India.
2. HTA involves systematically evaluating medical, economic, social, and ethical aspects of health technologies to inform policy decisions. It aims to maximize health benefits within limited budgets.
3. India has established the Health Technology Assessment Board to conduct HTAs and provide recommendations to guide public health programs and policies. However, developing local evidence and building capacity remains an ongoing challenge.
This document provides an overview of biomedical waste management rules and regulations in India. It defines biomedical waste and outlines the key steps for managing waste, including characterization, quantification, segregation, storage, transportation, treatment, and disposal. It discusses the current scenario of biomedical waste generation and treatment in India. It also summarizes the major differences between the 1998 and 2016 biomedical waste management rules, including changes to waste categories, treatment standards, and operator duties. Formats for authorization applications, annual reports, and accident reporting are also included.
The document outlines India's National Framework for Malaria Elimination from 2016-2030. The framework aims to eliminate malaria nationally by 2030 through several strategic approaches including categorizing states based on transmission and tailoring interventions accordingly. It outlines goals, objectives, interventions, milestones and targets to achieve elimination in different states by 2022, 2024, and 2027 to achieve national elimination by 2030. It also discusses measuring progress, cost implications, and cross-cutting interventions like surveillance, quality assurance and intersectoral collaboration needed.
The Rastriya Bal Swasthya Karyakram (RBSK) or Child Health Screening and Early Intervention Services Programme was launched in 2013 under India's National Health Mission. It aims to screen children from birth to 18 years for defects, diseases, deficiencies, and developmental delays. Mobile health teams screen children at anganwadi centers and schools. Children identified through screening are referred to District Early Intervention Centers for confirmation of diagnosis and free treatment. The programme aims to improve children's quality of life and reduce mortality and morbidity through early identification and intervention.
Revised National Tuberculosis Control ProgramAmol Kinge
- The document summarizes recent advances in India's Revised National Tuberculosis Control Programme (RNTCP).
- It provides details on tuberculosis epidemiology, classification, diagnosis, treatment regimens, and achievements of the RNTCP over time such as establishing infrastructure across India and treating millions of patients.
- Going forward, it discusses expanding daily treatment regimens to more districts, increasing private sector engagement, strengthening surveillance, and controlling TB in urban and special populations to work towards ending TB in India by 2030.
This document discusses tuberculosis (TB) epidemiology in India. It provides background on TB, including that it is caused by Mycobacterium tuberculosis bacteria and primarily affects the lungs. It then summarizes India's high TB burden, with 20% of global cases and high incidence, prevalence, and mortality rates. Key facts presented on India include that it has the world's highest TB burden, an annual risk of infection of 1.5%, and accounts for 66% of the Southeast Asia region's cases. Treatment success rates and trends in incidence, prevalence, and multi-drug resistant TB in India from 2011 are also briefly outlined.
Waste generated from medical facilities like hospitals can contaminate the environment if not properly disposed of. There are different categories of biomedical waste including infectious waste, sharp waste, and chemical/pharmaceutical waste. Improper management of biomedical waste poses health risks like infections. Proper practices like waste segregation, storage, transportation and treatment are required by law. Source reduction through minimizing waste generation and reuse is important to reduce the impact of biomedical waste. Public participation through education is needed to ensure safe disposal of all types of waste.
The document discusses the management of healthcare waste. It defines healthcare waste as any waste generated during diagnosis, treatment or immunization of humans or animals in healthcare facilities. It notes that healthcare waste requires safe handling due to its potential for infection and injury. It then outlines the types of healthcare waste and provides examples, as well as treatment and disposal options according to regulations. Finally, it discusses how healthcare waste is managed and treated in Pimpri Chinchwad, with waste being collected and transported daily to an incinerator facility.
Health technology assessment- Dr. Saraswathy MD, PGIMERYogesh Arora
This document provides an overview of health technology assessment (HTA), including its need, scope, and current status. It discusses:
1. The growing need for priority setting and efficient resource allocation in health systems has led to the rise of HTA globally and in India.
2. HTA involves systematically evaluating medical, economic, social, and ethical aspects of health technologies to inform policy decisions. It aims to maximize health benefits within limited budgets.
3. India has established the Health Technology Assessment Board to conduct HTAs and provide recommendations to guide public health programs and policies. However, developing local evidence and building capacity remains an ongoing challenge.
This document provides an overview of biomedical waste management rules and regulations in India. It defines biomedical waste and outlines the key steps for managing waste, including characterization, quantification, segregation, storage, transportation, treatment, and disposal. It discusses the current scenario of biomedical waste generation and treatment in India. It also summarizes the major differences between the 1998 and 2016 biomedical waste management rules, including changes to waste categories, treatment standards, and operator duties. Formats for authorization applications, annual reports, and accident reporting are also included.
The document outlines India's National Framework for Malaria Elimination from 2016-2030. The framework aims to eliminate malaria nationally by 2030 through several strategic approaches including categorizing states based on transmission and tailoring interventions accordingly. It outlines goals, objectives, interventions, milestones and targets to achieve elimination in different states by 2022, 2024, and 2027 to achieve national elimination by 2030. It also discusses measuring progress, cost implications, and cross-cutting interventions like surveillance, quality assurance and intersectoral collaboration needed.
The Rastriya Bal Swasthya Karyakram (RBSK) or Child Health Screening and Early Intervention Services Programme was launched in 2013 under India's National Health Mission. It aims to screen children from birth to 18 years for defects, diseases, deficiencies, and developmental delays. Mobile health teams screen children at anganwadi centers and schools. Children identified through screening are referred to District Early Intervention Centers for confirmation of diagnosis and free treatment. The programme aims to improve children's quality of life and reduce mortality and morbidity through early identification and intervention.
Revised National Tuberculosis Control ProgramAmol Kinge
- The document summarizes recent advances in India's Revised National Tuberculosis Control Programme (RNTCP).
- It provides details on tuberculosis epidemiology, classification, diagnosis, treatment regimens, and achievements of the RNTCP over time such as establishing infrastructure across India and treating millions of patients.
- Going forward, it discusses expanding daily treatment regimens to more districts, increasing private sector engagement, strengthening surveillance, and controlling TB in urban and special populations to work towards ending TB in India by 2030.
NVBDCP National Vector Borne Disease Control ProgramMihir Rupani
The document discusses guidelines for the National Vector Borne Disease Control Program (NVBDCP) in India. The NVBDCP is an integrated program that aims to prevent and control six vector-borne diseases - malaria, dengue, chikungunya, Japanese encephalitis, kala-azar, and filariasis. It outlines strategies like surveillance, diagnosis, treatment, vector control, capacity building, and inter-sectoral collaboration. Specific guidelines for malaria control include microscopy-based diagnosis, use of rapid test kits, indoor residual spraying, larviciding, epidemic preparedness, and training of health workers.
The document summarizes the key aspects of the Biomedical Waste Management Rules 2016 and its 2018 amendment in India. It defines biomedical waste and explains the importance of proper management. It outlines the classification of waste into 4 color-coded categories and their treatment and disposal options. It describes the steps of waste segregation, collection, transportation, and disposal. It highlights some major changes introduced in the 2018 amendment like phasing out of chlorinated plastic and establishing a barcode system.
Dr. Immanuel Joshua outlines key priorities and goals for ending tuberculosis (TB) globally and in India by 2025. The goals include reducing TB deaths and incidence rates by 90% and 80% respectively compared to 2015, and achieving zero catastrophic expenditures due to TB. Treatment duration and costs vary depending on whether TB is drug-sensitive or drug-resistant. India has committed to ending TB five years ahead of the global 2030 goal through its TB Free India campaign launched in 2018.
The document discusses bio-medical waste management issues and challenges faced by hospitals. It outlines various environmental laws related to waste management. It explains that healthcare waste includes waste generated in hospitals, laboratories, and research facilities. The basic principles of bio-medical waste management include segregation, containment, processing, storage and disposal of waste. Key challenges include lack of awareness, non-compliance with rules, inadequate protection of healthcare workers, and improper waste disposal. Addressing these issues requires robust policies, training, monitoring, and allocating sufficient resources.
1) The document discusses biomedical waste management, including types of biomedical waste, sources of healthcare waste, and treatment techniques.
2) It outlines the key steps of waste management including segregation, collection, storage, transportation, and treatment/disposal. Common treatment methods include incineration, autoclaving, and chemical disinfection.
3) Proper biomedical waste management is important to prevent environmental pollution and the spread of diseases. Healthcare facilities must adhere to regulatory guidelines for handling, treating and disposing different categories of waste.
The document discusses strategies for hospital waste management. It defines biomedical waste and outlines the key elements of the BMW Act and Rules, including classifications of waste, standards, and management steps. BMW is segregated into 4 categories and treated through various processes like incineration, autoclaving, or hydroclaving before disposal. Proper handling and treatment is important to reduce health and environmental risks from hazardous waste.
RNTCP guidelines for tuberculosis management: Extended versionRxVichuZ
This presentation is an extension of the already made presentation before, that deals with RNTCP guidelines for some special aspects encountered during tuberculosis management, other than management of individual diagnoses alone.
Have a look!
The document provides information on hospital waste management. It defines hospital waste and classifies it according to the WHO into 10 categories including general, pathological, sharps, infectious, chemical, radioactive, pharmaceutical, pressurized containers, genotoxic, and anatomical waste. It describes the sources of healthcare waste and the magnitude of the problem globally and in Nepal. The key aspects of healthcare waste management covered are segregation, collection, storage, transportation, treatment and disposal. Common treatment techniques discussed are incineration, chemical disinfection, thermal treatments, and land disposal. The document emphasizes the importance of proper waste management to prevent contamination and disease transmission.
The document summarizes the history of polio vaccination efforts including the development of the inactivated Salk vaccine in 1955 and the live oral Sabin vaccine in 1961. It describes the World Health Organization's goal in 1988 to eradicate polio globally by 2000 through vaccination campaigns. It provides details about India's Intensified Pulse Polio Immunization program launched in 1995 and national immunization days, highlighting challenges in reaching all children.
This document discusses methods for monitoring surgical site infections through air sampling in operating theaters. It reviews debates around whether air sampling or conventional swabbing is better. The document provides guidelines for effective air sampling, including using a slit sampler or air centrifuge to quantitatively measure bacterial colony counts. It recommends counts below 35 CFU per cubic meter for conventional theaters and 1 CFU for clean theaters. Overall it aims to establish best practices for regular air sampling to prevent surgical site infections through airborne contamination in operating theaters.
This document discusses biomedical waste management. It begins with an introduction about the importance of proper hospital waste management for patient and staff health. It then defines key terminology related to biomedical waste. It classifies healthcare waste into categories including biomedical waste, general waste, and other wastes. It describes the color coding and container types used for waste segregation. It provides guidelines for biomedical waste collection, packaging, labeling, and interim storage. It concludes with information on biomedical waste treatment and disposal facilities and specific COVID-19 waste handling guidelines.
Important maternal and child health parameters to evaluate quality care for the special group. Includes MMR, IMR, SBR, PMR, NMR, PNMR, U5MR. Practical class for UG 4th sem
Program, plan, policy, strategies and SWOT analysis of COPD in Nepal DeepakPandey315
This document discusses current policies, strategies and programs for the prevention, protection and control of chronic obstructive pulmonary disease (COPD) in Nepal. It finds that COPD is a major cause of death and hospitalization. Key risk factors include tobacco use, indoor air pollution from solid fuels, and outdoor air pollution. National policies aim to control tobacco, promote smokeless stoves, and reduce vehicular emissions. The WHO's MPOWER strategies and PEN package are implemented. Opportunities exist in multisectoral coordination, but stronger tobacco control and monitoring of air pollution are still needed.
Community Drug program , its succes and challengesKeshavsah8
This document discusses Nepal's Community Drug Program (CDP), its successes and challenges, and its relationship to Nepal's free health care services. It provides background on how CDP was established in Nepal based on models from African countries. CDP aims to ensure year-round availability of essential drugs through community participation and management of revolving drug funds. The document outlines several objectives and successes of CDP, including expanding access to drugs. However, it also notes initial problems and ongoing challenges like drug stock-outs. The implementation of national free health care created debates around how to manage CDP funds. The free services aim to fulfill health rights but face challenges in service provision, quality, and expanding coverage of treatments.
This document discusses guidelines for biomedical waste management according to the BMW rules of 1998, 2011, and 2016 in India. It defines biomedical waste and outlines the objectives of proper waste management. It describes the classification of waste into categories based on risk level and provides guidelines for segregation, treatment, and disposal of each waste category according to the color-coding system. The risks of improper waste management to health and the environment are also discussed.
National vector borne disease control programme 2 by nitin vermaKartikesh Gupta
The document summarizes India's National Vector Borne Disease Control Programme (NVBDCP) which aims to prevent and control vector-borne diseases like malaria, filariasis, kala azar, Japanese encephalitis, dengue, and chikungunya. The strategy includes disease management through early detection and treatment, integrated vector management using indoor spraying and larvivorous fish, and behavior change communication. The objectives are to reduce mortality from malaria, dengue, and JE by half and eliminate kala azar by 2010 and lymphatic filariasis by 2015. It provides recent case numbers and trends for these diseases and outlines prevention and control efforts.
The document summarizes the Kayakalp initiative launched by the Indian government to promote cleanliness and hygiene in public health facilities. The initiative recognizes and rewards facilities that achieve high scores on criteria assessing cleanliness, sanitation, waste management, and infection control. Facilities are evaluated through internal and peer assessments as well as external assessments by trained teams. Cash awards are given to the top performing facilities at the state and national level to invest in improving amenities and services. The document outlines the goals of Kayakalp and provides details on the assessment process, criteria, and cash prizes awarded to winning facilities in 2015-2016, 2016-2017.
The document discusses health care waste, including its sources, composition, and risks. It defines health care waste as any waste generated by health care establishments, including hospitals, clinics, laboratories, and homes. Approximately 75-90% is non-hazardous, similar to household waste, while 10-25% is hazardous and can pose health risks if not properly handled. The document then categorizes and describes different types of health care waste and the potential health hazards they pose if mismanaged.
The National Rural Health Mission (NRHM) was launched in 2005 to address deficiencies in India's rural health sector by improving access to quality health care, especially for poor women and children. It aims to reduce maternal and child mortality, provide universal access to public health services, and control communicable and non-communicable diseases. The evaluation assessed NRHM's implementation in 7 states and found improvements in health infrastructure and outcomes, but some gaps remain, such as inadequate numbers of community health workers. Recommendations include filling staff vacancies, improving emergency care and transportation, and retraining community health volunteers.
Bio Medical Waste Management And Handling Rules 1998ASHISH SINGH
The document discusses India's Bio-Medical Waste (Management and Handling) Rules 1998 which were established to regulate the management of biomedical waste from healthcare facilities. It defines biomedical waste and categories it based on potential hazards. The rules require all waste generators to treat and dispose of waste properly to prevent risks to public health and the environment. Facilities must segregate waste, maintain records, and report any accidents. The rules aim to formalize waste handling practices in India and prevent improper disposal of biomedical waste.
NVBDCP National Vector Borne Disease Control ProgramMihir Rupani
The document discusses guidelines for the National Vector Borne Disease Control Program (NVBDCP) in India. The NVBDCP is an integrated program that aims to prevent and control six vector-borne diseases - malaria, dengue, chikungunya, Japanese encephalitis, kala-azar, and filariasis. It outlines strategies like surveillance, diagnosis, treatment, vector control, capacity building, and inter-sectoral collaboration. Specific guidelines for malaria control include microscopy-based diagnosis, use of rapid test kits, indoor residual spraying, larviciding, epidemic preparedness, and training of health workers.
The document summarizes the key aspects of the Biomedical Waste Management Rules 2016 and its 2018 amendment in India. It defines biomedical waste and explains the importance of proper management. It outlines the classification of waste into 4 color-coded categories and their treatment and disposal options. It describes the steps of waste segregation, collection, transportation, and disposal. It highlights some major changes introduced in the 2018 amendment like phasing out of chlorinated plastic and establishing a barcode system.
Dr. Immanuel Joshua outlines key priorities and goals for ending tuberculosis (TB) globally and in India by 2025. The goals include reducing TB deaths and incidence rates by 90% and 80% respectively compared to 2015, and achieving zero catastrophic expenditures due to TB. Treatment duration and costs vary depending on whether TB is drug-sensitive or drug-resistant. India has committed to ending TB five years ahead of the global 2030 goal through its TB Free India campaign launched in 2018.
The document discusses bio-medical waste management issues and challenges faced by hospitals. It outlines various environmental laws related to waste management. It explains that healthcare waste includes waste generated in hospitals, laboratories, and research facilities. The basic principles of bio-medical waste management include segregation, containment, processing, storage and disposal of waste. Key challenges include lack of awareness, non-compliance with rules, inadequate protection of healthcare workers, and improper waste disposal. Addressing these issues requires robust policies, training, monitoring, and allocating sufficient resources.
1) The document discusses biomedical waste management, including types of biomedical waste, sources of healthcare waste, and treatment techniques.
2) It outlines the key steps of waste management including segregation, collection, storage, transportation, and treatment/disposal. Common treatment methods include incineration, autoclaving, and chemical disinfection.
3) Proper biomedical waste management is important to prevent environmental pollution and the spread of diseases. Healthcare facilities must adhere to regulatory guidelines for handling, treating and disposing different categories of waste.
The document discusses strategies for hospital waste management. It defines biomedical waste and outlines the key elements of the BMW Act and Rules, including classifications of waste, standards, and management steps. BMW is segregated into 4 categories and treated through various processes like incineration, autoclaving, or hydroclaving before disposal. Proper handling and treatment is important to reduce health and environmental risks from hazardous waste.
RNTCP guidelines for tuberculosis management: Extended versionRxVichuZ
This presentation is an extension of the already made presentation before, that deals with RNTCP guidelines for some special aspects encountered during tuberculosis management, other than management of individual diagnoses alone.
Have a look!
The document provides information on hospital waste management. It defines hospital waste and classifies it according to the WHO into 10 categories including general, pathological, sharps, infectious, chemical, radioactive, pharmaceutical, pressurized containers, genotoxic, and anatomical waste. It describes the sources of healthcare waste and the magnitude of the problem globally and in Nepal. The key aspects of healthcare waste management covered are segregation, collection, storage, transportation, treatment and disposal. Common treatment techniques discussed are incineration, chemical disinfection, thermal treatments, and land disposal. The document emphasizes the importance of proper waste management to prevent contamination and disease transmission.
The document summarizes the history of polio vaccination efforts including the development of the inactivated Salk vaccine in 1955 and the live oral Sabin vaccine in 1961. It describes the World Health Organization's goal in 1988 to eradicate polio globally by 2000 through vaccination campaigns. It provides details about India's Intensified Pulse Polio Immunization program launched in 1995 and national immunization days, highlighting challenges in reaching all children.
This document discusses methods for monitoring surgical site infections through air sampling in operating theaters. It reviews debates around whether air sampling or conventional swabbing is better. The document provides guidelines for effective air sampling, including using a slit sampler or air centrifuge to quantitatively measure bacterial colony counts. It recommends counts below 35 CFU per cubic meter for conventional theaters and 1 CFU for clean theaters. Overall it aims to establish best practices for regular air sampling to prevent surgical site infections through airborne contamination in operating theaters.
This document discusses biomedical waste management. It begins with an introduction about the importance of proper hospital waste management for patient and staff health. It then defines key terminology related to biomedical waste. It classifies healthcare waste into categories including biomedical waste, general waste, and other wastes. It describes the color coding and container types used for waste segregation. It provides guidelines for biomedical waste collection, packaging, labeling, and interim storage. It concludes with information on biomedical waste treatment and disposal facilities and specific COVID-19 waste handling guidelines.
Important maternal and child health parameters to evaluate quality care for the special group. Includes MMR, IMR, SBR, PMR, NMR, PNMR, U5MR. Practical class for UG 4th sem
Program, plan, policy, strategies and SWOT analysis of COPD in Nepal DeepakPandey315
This document discusses current policies, strategies and programs for the prevention, protection and control of chronic obstructive pulmonary disease (COPD) in Nepal. It finds that COPD is a major cause of death and hospitalization. Key risk factors include tobacco use, indoor air pollution from solid fuels, and outdoor air pollution. National policies aim to control tobacco, promote smokeless stoves, and reduce vehicular emissions. The WHO's MPOWER strategies and PEN package are implemented. Opportunities exist in multisectoral coordination, but stronger tobacco control and monitoring of air pollution are still needed.
Community Drug program , its succes and challengesKeshavsah8
This document discusses Nepal's Community Drug Program (CDP), its successes and challenges, and its relationship to Nepal's free health care services. It provides background on how CDP was established in Nepal based on models from African countries. CDP aims to ensure year-round availability of essential drugs through community participation and management of revolving drug funds. The document outlines several objectives and successes of CDP, including expanding access to drugs. However, it also notes initial problems and ongoing challenges like drug stock-outs. The implementation of national free health care created debates around how to manage CDP funds. The free services aim to fulfill health rights but face challenges in service provision, quality, and expanding coverage of treatments.
This document discusses guidelines for biomedical waste management according to the BMW rules of 1998, 2011, and 2016 in India. It defines biomedical waste and outlines the objectives of proper waste management. It describes the classification of waste into categories based on risk level and provides guidelines for segregation, treatment, and disposal of each waste category according to the color-coding system. The risks of improper waste management to health and the environment are also discussed.
National vector borne disease control programme 2 by nitin vermaKartikesh Gupta
The document summarizes India's National Vector Borne Disease Control Programme (NVBDCP) which aims to prevent and control vector-borne diseases like malaria, filariasis, kala azar, Japanese encephalitis, dengue, and chikungunya. The strategy includes disease management through early detection and treatment, integrated vector management using indoor spraying and larvivorous fish, and behavior change communication. The objectives are to reduce mortality from malaria, dengue, and JE by half and eliminate kala azar by 2010 and lymphatic filariasis by 2015. It provides recent case numbers and trends for these diseases and outlines prevention and control efforts.
The document summarizes the Kayakalp initiative launched by the Indian government to promote cleanliness and hygiene in public health facilities. The initiative recognizes and rewards facilities that achieve high scores on criteria assessing cleanliness, sanitation, waste management, and infection control. Facilities are evaluated through internal and peer assessments as well as external assessments by trained teams. Cash awards are given to the top performing facilities at the state and national level to invest in improving amenities and services. The document outlines the goals of Kayakalp and provides details on the assessment process, criteria, and cash prizes awarded to winning facilities in 2015-2016, 2016-2017.
The document discusses health care waste, including its sources, composition, and risks. It defines health care waste as any waste generated by health care establishments, including hospitals, clinics, laboratories, and homes. Approximately 75-90% is non-hazardous, similar to household waste, while 10-25% is hazardous and can pose health risks if not properly handled. The document then categorizes and describes different types of health care waste and the potential health hazards they pose if mismanaged.
The National Rural Health Mission (NRHM) was launched in 2005 to address deficiencies in India's rural health sector by improving access to quality health care, especially for poor women and children. It aims to reduce maternal and child mortality, provide universal access to public health services, and control communicable and non-communicable diseases. The evaluation assessed NRHM's implementation in 7 states and found improvements in health infrastructure and outcomes, but some gaps remain, such as inadequate numbers of community health workers. Recommendations include filling staff vacancies, improving emergency care and transportation, and retraining community health volunteers.
Bio Medical Waste Management And Handling Rules 1998ASHISH SINGH
The document discusses India's Bio-Medical Waste (Management and Handling) Rules 1998 which were established to regulate the management of biomedical waste from healthcare facilities. It defines biomedical waste and categories it based on potential hazards. The rules require all waste generators to treat and dispose of waste properly to prevent risks to public health and the environment. Facilities must segregate waste, maintain records, and report any accidents. The rules aim to formalize waste handling practices in India and prevent improper disposal of biomedical waste.
The document provides an overview of biomedical waste (BMW) in India, including its definition, categories, generation and management issues. Some key points:
- BMW includes waste generated from healthcare facilities and includes sharps, infectious, pathological and pharmaceutical waste.
- India generates over 3 million tonnes of BMW annually from over 95,000 healthcare facilities. Treatment and disposal of BMW is inadequate, posing risks to health and environment.
- The Biomedical Waste Rules of 1998 govern BMW management and require segregation, storage, transportation, treatment and disposal of different BMW categories. However, compliance remains a challenge.
The document outlines the key aspects of the Bio-Medical Waste Management Rules 2016 in India. It defines bio-medical waste as any waste generated during diagnosis, treatment or immunization of humans or animals. It categorizes waste into 4 categories - yellow, red, white and blue and specifies waste types in each category. The rules mandate segregation of waste at source into appropriate color coded bins, appointment of waste management committees in large hospitals, and duties of waste generators and operators. It aims to ensure proper management of biomedical waste in India.
Prof. Prashant Mehta's document discusses healthcare waste management in India. It begins by classifying different types of waste, including municipal solid waste, industrial waste, and bio-medical waste. It then provides details on India's regulatory framework for healthcare waste management. The Bio-Medical Waste Management and Handling Rules establish standards for segregating, transporting, treating, and disposing of different categories of bio-medical waste to prevent health and environmental risks. However, problems still exist in India with incomplete treatment and illegal dumping of untreated healthcare waste. Proper management of healthcare waste is important for public health.
The document discusses biomedical waste (BMW) management. It defines BMW and notes that it is generated from hospitals, clinics, labs, and other medical facilities. BMW is categorized based on infectivity and other hazardous properties. The key aspects of an effective BMW management program are waste segregation, collection, storage, transportation, and treatment. Occupational safety and regulatory compliance are also important. The document provides details on BMW rules and guidelines in India to help facilities properly manage this waste to protect human health and the environment.
This document provides information on biomedical waste (BMW) management in India. It defines BMW and outlines the types and proper treatment/disposal methods. Some key points include:
- BMW consists of potentially infectious waste generated at healthcare facilities that must be properly managed to protect workers and the public.
- Approximately 4.2 lakh kg of BMW is generated in India daily but only a portion is treated properly. Improper handling and disposal poses health risks.
- The Biomedical Waste Management Rules of 1998 provide guidelines for segregating, storing, transporting, and treating BMW according to the waste category to prevent health and environmental risks.
This document provides information on biomedical waste management in India. It discusses the rules and regulations around biomedical waste, including classification of waste into categories based on type. It also describes the process of waste generation, collection, treatment and disposal. Key points covered include outsourcing of waste management, recycling of plastics and other materials, and the roles and responsibilities of nurses in proper biomedical waste handling.
This document provides information on biomedical waste (BMW) management. It defines BMW and discusses its sources and categories. Significant amounts of hazardous BMW are generated daily, posing infection and toxicity risks if not properly handled. The World Health Organization estimates that 15% of hospital waste is infectious and has linked contaminated medical equipment to millions of viral infections annually. The document outlines Indian and international BMW rules and treatment/disposal methods. Proper segregation, containment, transport and treatment are necessary to safely manage this waste and protect public health.
This document provides information on a seminar about bio-medical waste management. It aims to provide knowledge on defining, classifying, and properly handling different types of bio-medical waste. It discusses WHO statistics on waste composition, classifications of waste, health hazards from improper handling, and rules and penalties around waste management. It also outlines the roles and responsibilities of nurses in ensuring proper bio-medical waste handling and disposal.
- Biomedical waste poses health and environmental risks if not properly managed. It is essential to have proper rules and practices for handling, treating and disposing of different categories of biomedical waste.
- The BMW Rules 2016 expanded the scope of regulated waste, established clearer operator duties, introduced a barcoding system, and emphasized safer treatment methods like hydroclave and plasma pyrolysis over incineration.
- The rules categorize biomedical waste into 4 color-coded categories and specify appropriate containment, treatment and disposal methods for each category to minimize risks to workers, patients and the environment.
Bio-medical waste refers to any waste generated during diagnosis, treatment, or research related to human or animal healthcare. Most bio-medical waste is non-infectious, but a portion is infectious or hazardous. Improper management of bio-medical waste can spread infection and disease. The Biomedical Waste Management Rules of 1998 were established in India to regulate the segregation, storage, transportation, treatment and disposal of different categories of bio-medical waste. Compliance with these rules and proper waste management procedures are necessary to safely handle bio-medical waste and prevent harm to human health and the environment.
Biomedical waste and hospital wastewater management.pptKAMAL_PANDEY123
Biomedical waste or hospital waste is any kind of waste containing infectious (or potentially infectious) materials.[1] It may also include waste associated with the generation of biomedical waste that visually appears to be of medical or laboratory origin (e.g. packaging, unused bandages, infusion kits etc.), as well research laboratory waste containing biomolecules or organisms that are mainly restricted from environmental release. As detailed below, discarded sharps are considered biomedical waste whether they are contaminated or not, due to the possibility of being contaminated with blood and their propensity to cause injury when not properly contained and disposed. Biomedical waste is a type of biowaste.
Biomedical waste may be solid or liquid. Examples of infectious waste include discarded blood, sharps, unwanted microbiological cultures and stocks, identifiable body parts (including those as a result of amputation), other human or animal tissue, used bandages and dressings, discarded gloves, other medical supplies that may have been in contact with blood and body fluids, and laboratory waste that exhibits the characteristics described above. Waste sharps include potentially contaminated used (and unused discarded) needles, scalpels, lancets and other devices capable of penetrating skin.
Biomedical waste is generated from biological and medical sources and activities, such as the diagnosis, prevention, or treatment of diseases. Common generators (or producers) of biomedical waste include hospitals, health clinics, nursing homes, emergency medical services, medical research laboratories, offices of physicians, dentists, veterinarians, home health care and morgues or funeral homes. In healthcare facilities (i.e. hospitals, clinics, doctor's offices, veterinary hospitals and clinical laboratories), waste with these characteristics may alternatively be called medical or clinical waste.
Biomedical waste is distinct from normal trash or general waste, and differs from other types of hazardous waste, such as chemical, radioactive, universal or industrial waste. Medical facilities generate waste hazardous chemicals and radioactive materials. While such wastes are normally not infectious, they require proper disposal. Some wastes are considered multihazardous, such as tissue samples preserved in formalin.
The document discusses biomedical waste management in hospitals. It defines different types of medical waste and their sources. It notes that most waste is non-infectious (80%) while pathological and infectious waste makes up 15%. It outlines 10 categories of biomedical waste and procedures for waste segregation, collection, storage, transportation, and treatment. Key steps include effective waste segregation at source using color coding, safe primary collection and storage, authorized transportation, and final treatment through incineration or other methods. Occupational safety and training of healthcare workers is also emphasized.
The document discusses biomedical waste management in India. It states that according to the Ministry of Environment and Forests, about 4,05,702 kg of biomedical waste is generated daily in India, but only 2,91,983 kg is properly disposed of. It also provides details on the categories and treatment/disposal methods of biomedical waste as specified in the Biomedical Waste Management Rules of India 2016. The rules categorize waste into yellow, red, white, blue and general waste and prescribe specific treatment methods like incineration, autoclaving, chemical disinfection etc. for different types of waste.
This document provides an overview of biomedical waste management. It defines biomedical waste and outlines its major sources. It classifies waste into different categories and discusses the need for proper management. The key steps in the management process are segregation, collection and storage, transportation, and treatment or disposal. Common treatment methods include incineration, autoclaving, chemical disinfection, and shredding. The document also discusses regulations, safety precautions, and the importance of training and awareness. Proper biomedical waste management is necessary to protect human health and the environment.
This document summarizes biomedical waste management practices in India. It defines biomedical waste and outlines the various types of waste generated from healthcare facilities. It discusses the legislation around biomedical waste management in India and the key responsibilities of waste generators and treatment facility operators. Proper waste segregation, packaging, transportation, treatment and disposal are essential to minimize health and environmental risks from biomedical waste. Regular monitoring and compliance are needed to effectively manage biomedical waste.
This document discusses biomedical waste management. It defines biomedical waste as waste generated during healthcare activities that requires safe handling due to potential pathogens. The waste is categorized as infectious, pathological, sharp, pharmaceutical, radioactive, and general. Proper management includes segregation, storage, transportation, and treatment of waste through incineration, autoclaving, or secured landfilling. Nurses play an important role in ensuring proper waste segregation and handling standards are followed within healthcare facilities. Failure to properly manage biomedical waste can spread infection and harm both healthcare workers and the environment.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Hiranandani Hospital in Powai, Mumbai, is a premier healthcare institution that has been serving the community with exceptional medical care since its establishment. As a part of the renowned Hiranandani Group, the hospital is committed to delivering world-class healthcare services across a wide range of specialties, including kidney transplantation. With its state-of-the-art facilities, advanced medical technology, and a team of highly skilled healthcare professionals, Hiranandani Hospital has earned a reputation as a trusted name in the healthcare industry. The hospital's patient-centric approach, coupled with its focus on innovation and excellence, ensures that patients receive the highest standard of care in a compassionate and supportive environment.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition